Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.41 |
| ▸ | POLRMT | O00411 | 1/20 | 0.33 |
| ▸ | ADK | P55263 | 5/20 | 0.33 |
| ▸ | ENTPD1 | P49961 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25967308 | 0.95 | TMPRSS2 (0.42) | TMPRSS2POLRMTADK | |
| SCHEMBL26326030 | 0.94 | TMPRSS2 (0.40) | TMPRSS2POLRMTADK | |
| SCHEMBL24305054 | 0.92 | TMPRSS2 (0.40) | TMPRSS2POLRMT | |
| SCHEMBL24339535 | 0.91 | TMPRSS2 (0.39) | TMPRSS2POLRMTADK | |
| SCHEMBL24339530 | 0.91 | TMPRSS2 (0.39) | TMPRSS2POLRMTADK | |
| SCHEMBL24339529 | 0.91 | TMPRSS2 (0.39) | TMPRSS2POLRMTADK | |
| SCHEMBL24304949 | 0.91 | TMPRSS2 (0.40) | TMPRSS2POLRMTADK | |
| SCHEMBL24305334 | 0.91 | TMPRSS2 (0.39) | TMPRSS2POLRMTADK | |
| SCHEMBL25968004 | 0.89 | TMPRSS2 (0.38) | TMPRSS2POLRMTADK | |
| SCHEMBL25967671 | 0.89 | TMPRSS2 (0.38) | TMPRSS2POLRMTADK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230287029-A1 | ANTIVIRAL PRODRUGS, PHARMACEUTICAL FORMULATIONS, AND METHODS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230287029-A1 | ANTIVIRAL PRODRUGS, PHARMACEUTICAL FORMULATIONS, AND METHODS | MTAP, SARS1, RNGTT | TMPRSS2 181/4885POLRMT 20/4885ADK 35/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.